...

Prof. Prakash Saudagar

PhD (IIT Guwahati)

Associate Professor

Department of Biotechnology

Room No: 414 +91-870-2462898
ps@nitw.ac.in Edit Profile Bio Sketch

Research Areas

 Cancer & Infectious Disease Drug Targets,

 Molecular Cell Biology & Protein Biochemistry

  • Courses Handled
  • Research IDs
  • Selected Publications
  • Project/Consultancy
  • Current PhD Students
  • Awards and Accolades
  • Additional Responsibilities
  • Molecular and Cellular Biology(BT16003)
  • Biology for Engineers(BT1161)
  • Genetic Engineering and Immunology Laboratory(BT306)
  • Cell Biology and Molecular Biology Laboratory(BT256)
  • Cell Biology(BT253)
  • Molecular and Cellular Biology(BT5102)
  • ORC ID: 0000-0001-7211-0581
  • ISI Researcher ID: ABE-7270-2020
  • SCOPUS ID: 54411376700
  • Google Scholar ID: Ql6HZjkAAAAJ&hl


  • 4’,7-dihydroxyflavone conjugated carbon nanotube formulation demonstrates improved efficacy against Leishmania parasite, By Sasidharan S. and; Prakash Saudagar*, Elsevier, BBA - General Subjects, vol.Volume 1867, Issue 10, pp.130416, 2023
  • An anti-leishmanial compound 4′,7-dihydroxyflavone elicits ROS-mediated apoptosis-like death in Leishmania parasite., By Sasidharan S. and; Prakash Saudagar*, FEBS Press, The FEBS Journal, vol.Volume 290, Issue 14, pp.3646-3, 2023
  • Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist., By S Sasidharan, K Radhakrishnan, JY Lee, Prakash Saudagar, V Gosu, D Shin, Public Library of Science, Plos one, vol.18(4): e0283364, pp.18, 2023
  • Pharmacophore-guided drug design using LdNMT as a model drug target for leishmaniasis., By B Sooram, U Mallikarjunachari, S Uddavesh, Prakash Saudagar*, Taylor & Francis, Journal of Biomolecular Structure and Dynamics, vol.1102, pp.0739, 2023
  • Critical Insight into Plausible Acquired Tocopherol Pathway in Neglected Human Trypanosomatids, By Santanu Sasidharan, Timir Tripathi, and Prakash Saudagar*, ACS Publications, ACS Omega, vol. 6, 47, 31396, pp.–31403, 2021
  • Biofunctionalized Chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacy., By Raj S.;Sasidharan S.;Tripathi T.; and Prakash Saudagar*, Elsevier, International Journal of Biological Macromolecules, vol.205, pp.211-19, 2022
  • Gold and silver nanoparticles functionalized with 4’,7-dihydroxyflavone exhibit activity against Leishmania donovani., By Sasidharan S. and; Prakash Saudagar*, Elsevier, Acta Tropica, vol.231, pp.106448, 2022
  • Knockout of Tyrosine Aminotransferase Gene by Homologous Recombination Arrests Growth and Disrupts Redox Homeostasis in Leishmania Parasite., By Sasidharan S. and; Prakash Saudagar*, Springer Nature, Parasitology Research, vol.121 (11) 3229-, pp.3241, 2023
  • Discovery of compounds inhibiting SARS-COV-2 multi-targets., By Sasidharan, Santanu, Neellohit Sarkar, and Prakash Saudagar*, Taylor & Francis , Journal of Biomolecular Structure and Dynamics:, vol.5, pp.2602-2, 2023

Investigating Universal Min-Circle Sequence Binding Protein (UMSBP) as a Therapeutic Target for Leishmaniasis Drug Development

  • Role Principal Investigator
  • Type Research
  • Sponsor ANRF, Govt. Of India
  • Duration 36 Months
  • Project Cost (INR) 6350000
  • Status Ongoing

Smart polymeric nanoparticles-based delivery system for the delivery of anti-tuberculosis drug

  • Role Co-Principal Investigator
  • Type Research
  • Sponsor SPARC
  • Duration 24 Months
  • Project Cost (INR) 2500000
  • Status Completed

Characterization and validation of tyrosine aminotransferase from Leishmania donovani as a potential drug target

  • Role Principal Investigator
  • Type Research
  • Sponsor SERB (DST, Govt. of India)
  • Duration 38 Months
  • Project Cost (INR) 4712000
  • Status Completed

Ultrasonic encapsulation of bioactive compounds to deliver in the food matrix

  • Role Co-Principal Investigator
  • Type Research
  • Sponsor DST Indo Russia Bilateral Project
  • Duration 24 Months
  • Project Cost (INR) 1800000
  • Status Completed

Studies on Mitogen-activated protein kinase of Leishmania parasite as a therapeutic target

  • Role Principal Investigator
  • Type Research
  • Sponsor SERB (DST, Govt. of India)
  • Duration 39 Months
  • Project Cost (INR) 2090000
  • Status Completed

Identification of novel drug candidates for leishmaniasis: Studies on redox enzymes of the parasite

  • Role Principal Investigator
  • Type Research
  • Sponsor Seed Grant, NITW
  • Duration 24 Months
  • Project Cost (INR) 500000
  • Status Completed


Ch Vihadhar Reddy

  • Area of Research: Exploring Drug Target Proteins in Leishmania Parasite

Gollapalli Seshaveena

  • Area of Research: Investigating the role IDPs in Leishmania Parasite
  • Associate Fellow
  • Best presentation Award
  • B.S Narasinga Rao Best presentation Award
  • Young Faculty Award
  • Young Scientist Award
  • Member, Project Assessment Panel, MSME Design Scheme (Continuing from August, 2023)
  • Head, Department of Biotechnology (July, 2023 - June, 2024)
  • Faculty-in-Charge, M. Tech II-Year (August, 2022 - August, 2023)
  • Faculty-in-Charge, Department MOUs – Academic & Industry I/c (July, 2019 - July, 2021)
  • Department NBA coordinator (January, 2019 - January, 2021)
  • Member, DAC UG (January, 2019 - August, 2021)
  • Warden IFC-B Mess (November, 2018 - December, 2020)
  • Faculty-in-Charge, Cell Biology Lab (Continuing from August, 2018)
  • Faculty-in-Charge, CD-ORD Facility, CIA (August, 2015 - January, 2022)
  • Member, DAC PG&R (July, 2014 - July, 2017)
  • Member, DAC UG (July, 2014 - July, 2017)
  • Faculty in-charge for Time-Table (December, 2013 - December, 2015)
  • Faculty in-charge for II. B. Tech. (November, 2013 - July, 2017)
  • Faculty-in-Charge, Molecular Biology & Genetics Lab (October, 2013 - August, 2021)